GDF15 and cardiac hypertrophy: Indeed, in hypertensive patients, GDF15 was positively associated with the thickness of posterior wall of the left ventricle and left ventricular mass [15] and treatment with recombinant GDF15 leads to a decrease in hypertrophy and reduced ventricular dilation in heart failure mice [16].